Assessment of midbrain atrophy in patients with progressive supranuclear palsy with routine magnetic resonance imaging.
about
Syndromes dominated by apraxia of speech show distinct characteristics from agrammatic PPA.Differentiation of progressive supranuclear palsy: clinical, imaging and laboratory tools.Magnetic resonance imaging in progressive supranuclear palsy.Movement disorders: role of imaging in diagnosis.Midbrain atrophy in vascular Parkinsonism.Utility of the Midbrain Tegmentum Diameter in the Differential Diagnosis of Progressive Supranuclear Palsy from Idiopathic Parkinson's Disease.Rates of brain atrophy and clinical decline over 6 and 12-month intervals in PSP: determining sample size for treatment trials.Cerebral peduncle angle: Unreliable in differentiating progressive supranuclear palsy from other neurodegenerative diseasesSpecificity and sensitivity of magnetic resonance imaging findings in the diagnosis of progressive supranuclear palsy.Neuroimaging comparison of primary progressive apraxia of speech and progressive supranuclear palsy.Midbrain atrophy is not a biomarker of progressive supranuclear palsy pathologyMagnetic resonance imaging for the diagnosis of Parkinson's disease.Radiological biomarkers for diagnosis in PSP: Where are we and where do we need to be?Role of magnetic resonance planimetry and magnetic resonance parkinsonism index in discriminating Parkinson's disease and progressive supranuclear palsy: a retrospective study based on 1.5 and 3 T MRI.[18F]-THK5351 PET Correlates with Topology and Symptom Severity in Progressive Supranuclear Palsy.Modeling trajectories of regional volume loss in progressive supranuclear palsy.The midbrain-to-pons ratio distinguishes progressive supranuclear palsy from non-fluent primary progressive aphasias.Simple linear brainstem MRI measurements in the differential diagnosis of progressive supranuclear palsy from the parkinsonian variant of multiple system atrophy.Manual MRI morphometry in Parkinsonian syndromes.MRI measurements of brainstem structures in patients with vascular parkinsonism, progressive supranuclear palsy, and Parkinson's disease.Imaging measures predict progression in progressive supranuclear palsy.Automatic identification of landmarks for standard slice positioning in brain MRI.Magnetic Resonance Parkinsonism Index: diagnostic accuracy of a fully automated algorithm in comparison with the manual measurement in a large Italian multicentre study in patients with progressive supranuclear palsy.In vivo evaluation of white matter pathology in patients of progressive supranuclear palsy using TBSS.A Visual Rating Scale for the Hummingbird Sign with Adjustable Diagnostic Validity.MRI measurements of brainstem structures in patients with Richardson's syndrome, progressive supranuclear palsy-parkinsonism, and Parkinson's disease
P2860
Q30544788-A69CB205-A77B-4AE2-8755-176C5ADEBF24Q30588544-8F18B1EF-27E2-40E7-9644-8B4F30DBF2FEQ33779124-6F422B8B-22EA-4CD6-BA31-DEFB21FF9B6EQ34136898-3EFBD453-62CF-4C26-BA67-719AB13EE7A5Q35460001-BDDDD575-5899-46DD-89FC-0B287284A17EQ35866128-61E2E7EB-9E9A-4AD3-8D7B-A9C81D63AE8FQ36101560-D151BB9B-84B3-45FE-B687-0B64C8704596Q36110771-9CFC03CC-198F-4CF9-B083-1EA250FBCA08Q36354065-AF75E1ED-4444-44B6-B062-A13D5174D9E8Q36565857-E2FE62C0-71B0-49EA-95C0-9FECA7E90455Q37170598-EEEFBD26-96B7-48AF-9057-D480104DCAEAQ39220904-A3413F7C-CE64-4199-A6B0-CEBCB3C8766CQ39303669-A1AE5877-2A5A-4E53-A0D2-99F90563148EQ47118856-67C7C3F4-BC52-4230-9C16-67722C01BE2AQ47547648-5CE70EB7-F26B-4B3C-BC06-B82D1BCA6743Q48090587-2E7002EA-3EE2-4B1C-8201-DB54DF5BCE58Q48136625-972AE57F-448D-4C81-B943-683B70CEBDF7Q48192424-16DA23DE-61EC-4639-BB92-FFA0676B5CFEQ48285702-57E38E32-E413-4BB0-BD30-0154927FC48EQ48360862-2E8D3E52-DDF5-4895-8AB7-239D8ACB00A5Q48616179-91E786B4-7131-47FA-9844-C8AF922F699AQ49054941-34AD4F65-157E-4ECA-909D-4C6FF41D8D6CQ50567708-2E164786-B66E-4464-8835-668CE4D4F002Q50776691-1DB263C8-EF3A-413B-8A0B-C851B9EDC796Q52148845-2A052ACD-CC60-4DEC-AEA1-96AF7E4DCDC1Q57911761-B6B9C304-A7B4-4759-B9B4-09FE49ED39C7
P2860
Assessment of midbrain atrophy in patients with progressive supranuclear palsy with routine magnetic resonance imaging.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Assessment of midbrain atrophy ...... ne magnetic resonance imaging.
@en
Assessment of midbrain atrophy ...... ne magnetic resonance imaging.
@nl
type
label
Assessment of midbrain atrophy ...... ne magnetic resonance imaging.
@en
Assessment of midbrain atrophy ...... ne magnetic resonance imaging.
@nl
prefLabel
Assessment of midbrain atrophy ...... ne magnetic resonance imaging.
@en
Assessment of midbrain atrophy ...... ne magnetic resonance imaging.
@nl
P2093
P2860
P50
P1476
Assessment of midbrain atrophy ...... ine magnetic resonance imaging
@en
P2093
Bartolozzi C
Cosottini M
Lazzarotti G
Michelassi MC
P2860
P356
10.1111/J.1600-0404.2006.00767.X
P407
P577
2007-07-01T00:00:00Z